|
| Betterchem |
|
|
|
| FDA approval activities
for this prescription drug:
Vaniqa (eflornithine hydrochlorine) Cream,13.9%, Bristol-Myers Squibb NDA 21-145 7/27/00 8/3/00 8/3/00 7/8/03 Vaniqa Indications: For the reduction of unwanted facial hair in women. EFLORNITHINE HYDROCHLORIDE Cream; Topical 13.9% VANIQA WOMEN FIRST |
© 2009 Betterchem.com
|